Table 1 Comparison of demographics and clinical features between patients with and without pathologic myopia.
From: Machine learning prediction of pathologic myopia using tomographic elevation of the posterior sclera
Variables | Overall | Healthy myopia eyes | Pathologic myopia eyes | P value† |
|---|---|---|---|---|
No. of eyes (%) | 860 (100) | 728 (84.65) | 132 (15.34) | |
Age (years old) | 52.43 ± 14.14 | 51.80 ± 13.83 | 55.89 ± 15.31 | 0.004 |
Male, n (%) | 510 (59.30) | 451 (61.95) | 59 (44.70) | < 0.001‡ |
Axial length (mm) | 26.00 ± 1.61 | 25.68 ± 1.23 | 27.75 ± 2.25 | < 0.001 |
BCVA (logMAR units) | 0.09 ± 0.16 | 0.06 ± 0.11 | 0.22 ± 0.28 | < 0.001 |
Classification of staphyloma, n (%) | ||||
Type 1, n (%) | 16 (1.86) | 0 | 16 (1.86) | |
Type 2, n (%) | 26 (3.02) | 0 | 26 (3.02) | |
Type 3, n (%) | 25 (2.91) | 0 | 25 (2.91) | |
Type 4, n (%) | 6 (0.70) | 0 | 6 (0.70) | |
Type 5, n (%) | 25 (2.91) | 0 | 25 (2.91) | |
Others, n (%) | 7 (0.81) | 0 | 7 (0.81) | |
Modified myopic maculopathy according to META-PM study, n (%) | ||||
Category 0 (no maculopathy) | 687 (79.88) | 663 (91.07) | 24 (18.18) | |
Category 1 (tessellated fundus) | 131 (15.23) | 65 (8.93) | 66 (50.0) | |
Category 2 (diffuse atrophy) | 28 (3.26) | 0 | 28 (21.21) | |
Category 3 (patchy atrophy) | 8 (0.93) | 0 | 8 (6.06) | |
Category 4 (macular atrophy) | 6 (0.70) | 0 | 6 (4.55) | |
Myopic CNV | 23 (2.67) | 0 | 23 (17.42) | |
Lacquer cracks | 17 (1.97) | 0 | 17 (12.89) | |
